Knowledge 29 April 2026
Vegan and Vegetarian Supplements in Europe: Capsules, Tablets and Manufacturing Considerations

Vegan and vegetarian supplements are becoming increasingly important in European private label manufacturing. Demand for plant-based products continues to grow.
In practice, developing vegan and vegetarian supplements is not only a positioning decision. It involves technical considerations related to ingredient sourcing, excipient selection, capsule materials, and manufacturing control within the EU regulatory framework.
This article explains how vegan and vegetarian supplements are developed in European manufacturing, with a focus on capsules and tablets, and what brands should consider before selecting this positioning.
Quick summary for brands
Vegan and vegetarian supplement manufacturing in Europe works best when:
- ingredient origin is clearly defined and documented
- capsule shell type is selected early (gelatin vs HPMC)
- excipients and coatings are compatible with plant-based positioning
- manufacturing processes account for cross-contamination risks
- labeling and claims align with EU expectations
Plant-based positioning is achievable—but only when formulation and manufacturing constraints are addressed from the beginning.
Why brands choose vegan and vegetarian supplements
Demand for vegan and vegetarian supplements continues to increase across European markets.
Brands choose this positioning for several reasons:
- alignment with plant-based lifestyles
- broader consumer acceptance
- perceived product transparency and quality
- differentiation in competitive supplement categories
In many cases, vegan positioning is no longer a niche—it is becoming a standard expectation in categories such as daily wellness, magnesium, and multivitamin products.
Vegan vs vegetarian — what is the difference in practice
Although often grouped together, vegan and vegetarian supplements are not identical.
- Vegetarian supplements may include animal-derived ingredients such as dairy or gelatin
- Vegan supplements exclude all animal-derived components
From a manufacturing perspective, the key differences relate to:
- capsule shell materials
- excipients and processing aids
- raw material sourcing and documentation
Defining the target positioning early is essential to avoid reformulation later in the project.
Vegan capsules and tablets in EU manufacturing
Capsules and tablets are the most widely used formats for vegan and vegetarian supplements in Europe.
Both formats are generally suitable for plant-based positioning, but they require careful selection of raw materials and manufacturing processes.
Capsules (HPMC vs gelatin)
For capsules, the most important factor is the capsule shell material.
- Gelatin capsules are animal-derived and not suitable for vegan products
- HPMC (hydroxypropyl methylcellulose) capsules are plant-based and widely used in vegan supplement manufacturing
HPMC capsules are compatible with most formulations and are commonly used in EU private label projects. However, they may differ slightly in:
Ready-made capsule formulas are already developed and can be made under your brand in an HPMC shell: ready-made capsule formulas in a plant-based HPMC shell.
- moisture behavior
- mechanical properties
- cost structure
For more detail, see our guide on Private Label Capsule Manufacturing in Europe.
Tablets and vegan formulation considerations
Tablets can be produced as vegan products, but only if all formulation components meet plant-based requirements.
Key factors include:
- plant-based binders and fillers
- coatings without animal-derived ingredients
- compatible processing aids
In practice, tablets are often one of the most straightforward formats to adapt for vegan positioning.
Ready-made tablet formulas are already developed, with an HPMC film coat rather than an animal-derived one: ready-made tablet formulas with an HPMC film coat.
For manufacturing considerations, see Private Label Tablet Manufacturing in Europe.
Ingredient sourcing and formulation constraints
Achieving vegan or vegetarian positioning depends on the entire formulation—not only the dosage form.
Important considerations include:
- origin of active ingredients
- use of carriers and stabilizers
- presence of hidden animal-derived components
- supplier documentation and traceability
Certain ingredients may have multiple sourcing options, making supplier verification essential.
Cross-contamination and manufacturing control
Even when all ingredients are plant-based, manufacturing conditions must be considered.
Potential risks include:
- shared production lines with non-vegan products
- cross-contact with gelatin-based materials
- insufficient cleaning validation
In EU manufacturing, full segregation is not always required, but risk assessment and process control must be documented.
Clear communication with the manufacturer ensures that vegan positioning is technically supported.
Regulatory and labeling considerations in the EU
In the European Union, vegan and vegetarian claims are not defined by a single harmonized regulation.
However, food supplements must comply with general food law and labeling requirements.
In the EU, food supplements are regulated under Directive 2002/46/EC and must comply with general food law, including Regulation (EC) No 178/2002.
From a practical perspective, this means:
- claims must not be misleading
- ingredient origin must be verifiable
- labeling must reflect actual product composition
Some brands choose third-party vegan certifications, but these are voluntary and market-driven.
Packaging considerations for vegan supplements
Packaging does not define vegan status, but it influences positioning and product stability.
Important considerations include:
- compatibility with product shelf life
- alignment with sustainability expectations
- suitability for capsules or tablets
For example, bottles and blister packaging are commonly used for vegan capsules and tablets in EU manufacturing.
For more detail on stability, see our guide on supplement shelf life in Europe.
What brands should prepare before contacting a manufacturer
To develop vegan or vegetarian supplements efficiently, brands should define:
Product concept
- vegan or vegetarian positioning
- target EU market
- consumer group
Formulation
- ingredient list and origin
- capsule or tablet format
- restrictions (e.g. no gelatin, no lactose)
Quality & compliance
- intended claims
- certification requirements
- target shelf life
Packaging
- bottle or blister format
- labeling requirements
- sustainability expectations
Timeline
- launch window
- new product or reformulation
Providing this information early allows manufacturers to assess feasibility without delays.
How vegan supplements fit into private label manufacturing
In private label manufacturing, vegan supplements are typically:
- based on plant-derived or synthetic ingredients
- produced using HPMC capsules or tablet formats
- evaluated based on formulation feasibility and process control
At PharmaEurope, vegan feasibility is assessed during early project evaluation to ensure alignment between formulation, manufacturing, and regulatory requirements.
Final takeaway
Vegan and vegetarian supplements in Europe require more than a label claim—they depend on formulation design, capsule selection, and manufacturing control.
Capsules and tablets are the most practical formats for plant-based positioning, but both require careful evaluation of ingredient origin and production conditions.
Brands that define these factors early are more likely to achieve stable products and consistent regulatory compliance.
Next step
If you are considering vegan or vegetarian supplements in Europe, align early on:
- ingredient sourcing
- capsule or tablet selection
- manufacturing compatibility
- labeling and claims
Early alignment reduces reformulation risk and supports efficient production.
Thinking about your own product? Tell us the format, the active and its dose, and how many units you need for the first run. Ready-made formulas start from 100 units, and we reply within 24 hours, Monday to Friday.
Written by the PharmaEurope manufacturing team at the ISO 22000-certified plant in the European Union. Last reviewed 29 April 2026.
Where this is made
Request a quoteReady-made formulas from 100 units. We reply within 24 hours, Monday to Friday.
Read next
Private label vitamin D3 + K2 and vegan vitamin D3PharmaEurope makes private label vitamin D3 + K2 in softgels, tablets and effervescent tubes of 20, and vegan vitamin D3 from algae, at our EU plant. White label starts from 100 units, standard own-label runs from 500 bottles (500 pcs for stock softgels), your own brand on a ready-made formula is in production from 2 […]27 October 2026
Why vitamin D is a strong first product for your supplement brandVitamin D is a strong first product for a new supplement brand because the ingredient is well known to buyers, the product is taken every day and the EU allows seven authorised health claims for it. PharmaEurope manufactures private label vitamin D in its certified EU plant: white label on a ready-made formula from 100 […]27 October 2026
What vitamin D does and what an EU label may sayIn the EU, what vitamin D does may be stated on a supplement label only in the seven authorised health claims of Regulation (EU) No 432/2012, for example "Vitamin D contributes to the maintenance of normal bones", and only when a daily serving supplies at least 15 % of the 5 µg NRV, which is […]27 October 2026